ABOUT

Press Releases

November 1, 2021

AMP Leaders Publish Recommendations to Improve Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks

New JAMA Health Forum article lays the foundation for a comprehensive national testing strategy that will promote better collaboration between public health and diagnostic laboratories and test manufacturers.

Continue Reading


October 29, 2021

Association for Molecular Pathology Announces 2021 Award Recipients

Jennifer Doudna, Charles Hill & Marina Nikiforova Honored for Contributions to the Molecular Diagnostics Field and Community

Continue Reading


July 29, 2021

AMP Publishes Recommendations to Facilitate Widespread Adoption of Genetic Variant Data Sharing Practices

AMP encourages robust variant data sharing through public repositories to help address health inequities, advance precision medicine, and improve clinical diagnosis and care for patients with cancer and rare inherited disorders.

Continue Reading


June 24, 2021

AMP Announces Results of 2021 Leadership Elections

AMP has announced the results of its recent elections for 2021 Leadership positions. AMP is an organization driven by the dedication of its volunteers and looks forward to working with these newly elected leaders.

Continue Reading


June 10, 2021

AMP Recommends Minimum Set of Pharmacogenetic Alleles to Guide Clinical CYP2D6 Genotype Testing, Promote Standardization, and Improve Patient Care

Latest joint consensus guideline authored by representatives from AMP, CAP, Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy

Continue Reading


May 18, 2021

Association for Molecular Pathology and Association of Pathology Chairs Call on Congress to Pass the Verified Innovative Testing in American Laboratories (VITAL) Act

Legislation would enhance transparency, preserve innovation, and ensure broad patient access
to essential laboratory developed testing procedures

Continue Reading


March 16, 2021

New AMP Report Reignites Effort for Appropriate Reimbursement for Professional Analysis, Interpretation, and Reporting of Molecular Diagnostic Testing Procedures

Survey reveals that current payment systems do not account for all of the time spent by qualified healthcare professionals to interpret and integrate results within the context of a patient’s diagnosis

Continue Reading


February 23, 2021

Latest Association for Molecular Pathology Survey Findings Indicate Significant Decline in Molecular Testing for Cancer During COVID-19 Pandemic

Laboratory staffing and supply shortages are limiting patient access to critical cancer screening tests that guide treatment decisions

Continue Reading


January 22, 2021

AMP Reinforces Continued Commitment to Improving National Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks

New AMP COVID Response Steering Committee will lead the organization’s cross-functional effort to address clinical needs and ensure more Americans have timely access to high-quality testing procedures

Continue Reading


October 8, 2020

AMP Releases Preliminary Results to Second 2020 Nationwide SARS-CoV-2 Molecular Testing Survey

Demand for COVID-19 diagnostic testing continues to rise as clinical laboratories face significant staffing shortages and persistent supply chain issues

Continue Reading


September 10, 2020

AMP Announces 2020 Award Recipients

Dennis Lo, Karen Mann & Ronald Przygodzki Honored for Contributions to the Field & Molecular Pathology Community

Continue Reading


August 21, 2020

AMP Commends Department of Health and Human Services on Decision to Lessen Regulatory Burden on Laboratory Professionals

Modernizing the CLIA Regulations is the Best Approach to Ensuring High Quality and Rapid Response Testing

Continue Reading


July 10, 2020

AMP Announces 2020 Election Results

AMP has announced the results of its recent elections for 2020 Leadership positions. AMP is an organization driven by the dedication of its volunteers and looks forward to working with these newly elected leaders.

Continue Reading


June 17, 2020

An Open Letter to AMP Members: Fostering Forward Movement Against Racism and Inequality

AMP stands in solidarity with the Black community in this fight against racial inequality and race-based violence. We strongly condemn systemic racism and the recent acts of violence.

Continue Reading


May 28, 2020

AMP Releases Preliminary Results to Nationwide SARS-CoV-2 Molecular Testing Survey

More than 100 clinical laboratory professionals across the US provide feedback on COVID-19 diagnostic testing environment and offer recommendations to improve future pandemic responses

Continue Reading


May 5, 2020

AMP Recommends Minimum Set of Pharmacogenetic Alleles to Help Standardize Clinical Genotyping Testing for Warfarin Response

Latest joint guideline from AMP and CAP completes series of three reports designed to aid assay design, increase concordance across laboratories and improve patient care.

Continue Reading


May 4, 2020

AMP Expresses Support for Citizen Petition from the Coalition to Preserve Access to Pharmacogenomics Information

AMP recommends remedies to address consequences of recent FDA actions and improve patient care.

Continue Reading




September 19, 2019

Association for Molecular Pathology Announces 2019 Award Recipients

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented this November during AMP’s 25th Annual Meeting & Expo.

Continue Reading


September 4, 2019

AMP Recommends Clinical Pharmacogenomic Testing Best Practices to Preserve Broad Access and Improve Patient Care

Key recommendations include well established clinical validity and comprehendible test reports for healthcare providers

Continue Reading


July 1, 2019

AMP Announces Results of 2019 Leadership Elections

AMP has announced the results of its recent elections for 2019 Leadership positions. AMP is an organization driven by the dedication of its volunteers and looks forward to working with these newly elected leaders.

Continue Reading


June 10, 2019

AMP Bolsters Position on Consumer Genomic Testing

Updated position statement reflects emerging technology landscape, highlights privacy best practices, and expands conditions for clinically-meaningful tests

Continue Reading


June 4, 2019

AMP Expresses Serious Concerns with Congress' Attempt to Resurrect Human Gene Patenting Debate and Reverse Settled Supreme Court Ruling

Draft legislation would overturn 150 years of patent case law, prevent the development of life-saving diagnostics for devastating diseases, dramatically increase drug costs, and significantly limit access to optimal patient care

Continue Reading


May 9, 2019

AMP Recommends Minimum Set of Alleles for All Clinical CYP2C9 Genotyping Testing

A new joint report from AMP and CAP shares consensus, evidence-based recommendations to aid in the design and validation of clinical CYP2C9 assays, promote standardization of testing across different laboratories and improve patient care.

Continue Reading


February 1, 2019

More than 60 Leading Health Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing

Stakeholders urge the Centers for Medicare and Medicaid Services (CMS) to revise its interpretation of the National Coverage Determination (NCD) for Next Generation Sequencing (NGS), expressing serious concerns that the overly broad interpretation will restrict patient access to medically necessary and relevant clinical tests and adversely impact cancer care and outcomes.  

Continue Reading


August 22, 2018

Association for Molecular Pathology Announces 2018 Award Recipients

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented in November during the AMP 2018 Annual Meeting in San Antonio, Texas.

Continue Reading


August 21, 2018

AMP Addresses Clinical Relevance of DNA Variants in Chronic Myeloid Neoplasms

AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals with the management of most Chronic Myeloid Neoplasms (CMNs) and development of high-throughput pan-myeloid sequencing testing panels. The report, “Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms (CMNs): A Report of the Association for Molecular Pathology,” was released online ahead of publication in The Journal of Molecular Diagnostics.

Continue Reading


July 26, 2018

AMP Announces Results of 2018 Leadership Elections

AMP has announced the results of its recent elections for 2019 Leadership positions. AMP is an organization driven by the dedication of its volunteers and looks forward to working with these newly elected leaders.

Continue Reading


February 27, 2018

AMP Publishes Recommendations for Clinical CYP2C19 Genotyping Allele Selection

AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals when designing and validating clinical CYP2C19 assays, promote standardization of testing across different laboratories and complement existing clinical guidelines.

Continue Reading


January 23, 2018

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have updated their joint 2013 evidence-based guideline to ensure that clinicians stay apace with rapid advancements and provide optimal patient care.

Continue Reading


January 17, 2018

CancerLinQ LLC Enters Collaboration with the Association for Molecular Pathology

Cooperation Will Harness Expertise from Emerging Field of Molecular Pathology to Broaden ASCO’s CancerLinQ® Platform

Continue Reading


November 16, 2017

Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists

Latest report completes series of best practice guidelines designed to improve entire NGS workflow and ensure optimal results for better patient care.

Continue Reading


September 5, 2017

AMP Announces 2017 Award Recipients

AMP has announced the recipients of the Jeffrey A. Kant Leadership Award and the AMP Meritorious Service Award. Together with the AMP Award for Excellence in Molecular Diagnostics, these awards will be presented at the AMP 2017 Annual Meeting.

Continue Reading


July 14, 2017

AMP to Recognize Andrew P. Feinberg, MD, MPH with 2017 Award for Excellence in Molecular Diagnostics

Epigenetics pioneer to receive Association's highest honor at upcoming Annual Meeting

Continue Reading


July 13, 2017

AMP Announces Results of 2017 Leadership Elections

AMP announced the results of its 2017 Leadership Elections. AMP is an organization driven by the dedication of its volunteers and looks forward to working with these newly elected leaders.

Continue Reading


March 22, 2017

AMP Issues Best Practice Guidelines for Next-Generation Sequencing-based Oncology Panel Validation

AMP's consensus recommendations will help clinical laboratory professionals achieve high-quality sequencing results and deliver better care for cancer patients.

Continue Reading


February 6, 2017

ASCP, CAP, AMP, ASCO Issue Molecular Biomarkers for the Evaluation of Colorectal Cancer Guidelines

This pivotal guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer. The guideline will aid in establishing standard molecular marker testing to help guide targeted therapy decisions, and advance personalized care for colorectal cancer patients.

Continue Reading


December 16, 2016

AMP Issues New Joint Guidelines to Standardize Interpretation and Reporting of Sequence Variants in Cancer

Clinical laboratory and oncology experts collaborate to publish evidence-based somatic variant classification system to improve patient care

Continue Reading


November 21, 2016

AMP Applauds FDA's Decision to Delay Final Regulatory Guidance for Laboratory Developed Procedures

Organization of molecular diagnostics professionals reaffirms commitment to preserving broad access to essential patient care.

Continue Reading


October 19, 2016

AMP Explores New Technological Advancements to Improve Diagnosis and Optimize Treatment Selection for Invasive Infectious Diseases

AMP has announced a new report that examines how sophisticated technology advancements are being implemented to improve diagnosis and optimize treatment selection for multiple invasive, opportunistic and often deadly infectious diseases. The manuscript titled “Emerging and Future Applications of MALDI-TOF Mass Spectrometry in the Clinical Microbiology Laboratory: A Report of the Association for Molecular Pathology” has been released online ahead of publication in the November 2016 issue of The Journal of Molecular Diagnostics.

Continue Reading


September 26, 2016

AMP Announces 2016 Award Recipients

AMP has announced the recipients of the Jeffrey A. Kant Leadership Award and the AMP Meritorious Service Award. Together with the AMP Award for Excellence in Molecular Diagnostics, these awards will be presented at the AMP 2016 Annual Meeting.

Continue Reading


September 22, 2016

AMP Appreciates Opportunity to Discuss with Congressional Leaders How Laboratory Developed Procedures Benefit Patient Care

AMP recently participated in two events designed to help educate lawmakers and congressional staff about laboratory developed procedures (LDPs) and the vital role they play in precision medicine and patient care. Both the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) Hearing and the Co-hosted Congressional Briefing provided bipartisan forums for AMP leaders to discuss how LDPs are currently designed, validated, regulated, and used in a variety of clinical settings.

Continue Reading


September 7, 2016

AMP to Recognize Eric Lander with 2016 Award for Excellence in Molecular Diagnostics

Association's highest honor for lifetime of achievements to be presented during Annual Meeting

"As one of the true early pioneers of the human genome, Dr. Eric Lander is a well-deserved recipient of the AMP Award for Excellence in Molecular Diagnostics," said Charles E. Hill, MD, PhD, AMP President.. "Throughout his career, Dr. Lander and his colleagues have developed tools and applied methods that have transformed our understanding of the molecular basis of rare and common genetic diseases, including cancer. His seminal publications, fundamental discoveries, and significant scientific contributions have had a massive impact on human health by providing us with the framework for the modern practice of clinical molecular diagnostics."

Continue Reading


August 17, 2016

AMP Establishes New Standard for Clinical Utility of Molecular Diagnostics for Inherited Diseases and Cancer

New JMD report recognizes value of testing procedures and promotes paradigm corrections to drive widespread adoption of a more proactive, patient-centered approach to modern healthcare

“Molecular pathology testing procedures are vital tools for insight and analysis into various aspects of clinical practice,” said Roger D. Klein, MD, JD, AMP Professional Relations Chair. “However, we need a more practical and patient-centered approach for evaluating clinical usefulness before we can truly deliver the promise of precision medicine.”

Continue Reading


April 13, 2016

AMP Releases Results from 2015 Genomic Sequencing Procedure Microcosting and Health Economic Cost-Impact Analyses

New publication in The Journal of Molecular Diagnostics describes cost and value analysis of gene panels including non-small cell lung cancer, exome sequencing, and hearing loss gene panels

"Genomic Sequencing Procedures are changing the way clinicians are diagnosing and managing hereditary diseases and the delivery of oncology care," said Linda Sabatini, PhD, HCLD, First Author and Project Leader, Director of Molecular Diagnostics at NorthShore University HealthSystem. "We hope that laboratories will use these tools to assess their individual costs, to consider the value structure in their own patient populations, and to contribute their data to the ongoing dialogue regarding the impact of GSPs on improving patient care."

Continue Reading


March 14, 2016

AMP Issues Statement Regarding FDA Letters to Two Texas Hospitals about Rapid Detection Zika Test

AMP is very concerned and disappointed to see the FDA taking enforcement action against the physicians at Texas Children's Hospital and Houston Methodist Hospital for their laboratory developed procedure (LDP) for Zika virus, which was designed to identify virus-specific RNA sequences in a large metropolitan area. Given the ongoing outbreak of the infection and risk of infection in the Houston area, these types of tests are critical for patient care and should be made available to these patients in need.

Continue Reading


February 5, 2016

AMP Updates Pathology Residency Curriculum Recommendations

New report published in The Journal of Molecular Diagnostics focuses on improving pathology training programs for molecular pathology and genomic medicine

The AMP paper provides residency programs with specific recommendations from subject matter experts on 10 major molecular pathology topics: basic molecular pathology goals and laboratory management; basic concepts in molecular biology and genetics; technology; inherited disorders; oncology; infectious diseases; pharmacogenetics; histocompatibility and identity; genomics, and information management.

Continue Reading






















October 18, 2012

AMP Publishes Report on NGS

Report provides overview of possibilities, challenges, and applications of next-generation sequencing

Continue Reading


September 26, 2012

AMP Appeals Breast Cancer Gene Patent Case to U.S. Supreme Court

Case Challenges Patents as Dangerous Roadblock to Patient Care, Medical Innovation

Continue Reading


June 13, 2012

AMP Receives 40% Increase in Abstract Submissions

The record-breaking number of abstract submissions for the AMP 2012 Annual Meeting on Genomic Medicine is consistent with the increased number of exhibiting companies and anticipated number of attendees.

Continue Reading


May 22, 2012

AMP Developing a CPT Coding Proposal for Next Generation Sequencing

Proposal to be completed by the end of June and released for feedback from stakeholders in the laboratory and payer community before submission of a formal proposal to the AMA CPT Editorial Panel.

Continue Reading


May 2, 2012

AMP Forms Working Group to Further Consider Oversight of Lab Tests

The goal of the group is to produce a white paper that will outline the key issues, and provide AMP's recommendations for future LDT oversight.

Continue Reading


March 27, 2012

AMP Optimistic in Suit to invalidate Patents on Breast Cancer Genes

AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer.

Continue Reading


March 21, 2012

AMP Applauds Supreme Court Ruling: Sees Win for Patients and Personalized Medicine

AMP is encouraged by the Court's recognition that Prometheus patents neither promote the advancement of medical practice, nor benefit patient care.

Continue Reading


February 16, 2012

AMP Requests Moratorium on Human Gene Patenting

AMP testified at the U.S. Patent and Trademark Office hearing regarding patents on human genes.

Continue Reading


February 6, 2012

New Governance Structure Approved by AMP Membership

AMP adopts change in governance structure as part of newly implemented strategic plan.

Continue Reading


Corporate Partners